T. Laursen, A. Flyvbjerg, J. O. L. Jorgensen and R. C Baxter, “Stimulation of the 150-Kilodalton Insulin-Like Growth Factor-Binding Protein-3 Ternary Complex by Continuous and Pulsatile Patterns of Growth Hormone (GH) Administration in GH-Deficient Patients,” The Journal of Clinical Endocrinology & Metabolism, Vol. 85, No. 11, 2000, pp. 4310-4314. http://dx.doi.org/10.1210 /jc.85.11.4310
 M. M. Rechler and D. R. Clemmons, “Regulatory Actions of Insulin-Like Growth Factor-Binding Proteins,” Trends Endocrinology Metabolism, Vol. 9, No. 5, 1998, pp. 176-183. http://dx.doi.org/10. 1016/S1043-2760(98)00047-2
 S. M. Firth and R. C. Baxter, “Cellular Actions of the Insulin-Like Growth Factor Binding Proteins,” Endocrinology Review, Vol. 23, No. 6, 2002, pp. 824-854. http://dx.doi.org/10.1210/er.2001-0033
 J. Hong, G. Zhang, F. Dong and M. M. Rechler, “Insulin-Like Growth Factor (IGF)-Binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells,” Journal of Biological Chemistry, Vol. 277, No. 12, 2002, pp. 10489-10497. http://dx.doi.org/10.1074/ jbc.M109604200
 N. Bhattacharyya, K. Pechhold, H. Shahjee, et al., “Non-Secreted Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-Independent Mechanisms without Being Concentrated in the Nucleus,” Journal of Biological Chemistry, Vol. 281, No. 34, 2006, pp. 24588-24601. http://dx.doi.org/10.1074/jbc.M509463200
 R. Rajah, B. Valentinis and P. Cohen, “Insulin-Like Growth Factor (IGF)-Binding Protein-3 Induces Apoptosis and Mediates the Effects of Transforming Growth Factor-Beta1 on Programmed Cell Death through a p53-and IGF-Independent Mechanism,” Journal of Biological Chemistry, Vol. 272, No. 18, 1997, pp. 12181-12188. http://dx.doi.org/10.1074/jbc.272.18.12181
 A. J. Butt, K. A. Fraley, S. M. Firth and R. C. Baxter, “IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation IN Human Breast Cancer Cells,” Endocrinology, Vol. 143, No. 7, 2002, pp. 2693-2699. http://dx.doi.org/10.1210 /en.143.7.2693
 K.W.Lee, L. Ma, X. Yan, et al., “Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-Like Growth FactorIndependent Nucleomitochondrial Translocation of RXRalpha/Nur77,” Journal of Biological Chemistry, Vol. 280, No. 17, 2005, pp. 16942-16948. http://dx.doi.org/10.1074/jbc.M412757200
 L. J. Schedlich, T. F. Young, S. M. Firth and R. C. Baxter, “Insulin-Like Growth Factor-Binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells,” Journal of Biological Chemistry, Vol. 273, No. 29, 1998, pp. 18347-18352. http://dx.doi.org/ 10.1074/jbc.273.29.18347
 A. Spagnoli, M. Torello, S. R. Nagalla, et al., “Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis,” Journal of Biological Chemistry, Vol. 277, No. 21, 2002, pp. 18860-18867. http://dx.doi.org/10.1074/jbc.M200218200
 G. Zappalà and M. M. Rechler, “IGFBP-3, Hypoxia and TNF-Alpha Inhibit Adiponectin Transcription,” Biochemical and Biophysical Research Communications, Vol. 382, No. 4, 2009, pp. 785-789. http://dx.doi.org/10.1016/j.bbrc. 2009.03.112
 S. M. Leal, S. S. Huang and J. S. Huang, “Interactions of High Affinity Insulin-Like Growth Factor-Binding Proteins with the Type V Transforming Growth Factor-Betareceptor in Mink Lung Epithelial Cells,” Journal of Biological Chemistry, Vol. 274, No. 10, 1999, pp. 6711-6717. http://dx.doi.org/10. 1074/ jbc.274.10.6711
 L. C. Giudice, E. M. Farrell, H. Pham, et al., “InsulinLike Growth Factor Binding Proteins in Maternal Serum throughout Gestation and in the Puerperium: Effects of a Pregnancy-Associated Serum Protease Activity,” The Journal of Clinical Endocrinology & Metabolism, Vol. 71, No. 4, 1990, pp. 806-816. http://dx.doi.org/10.1210/jcem-71-4-806
 P. Angelloz-Nicoud, C. Lalou and M. Binoux, “Prostate Carcinoma (PC-3) Cell Proliferation Is Stimulated by the 22 - 25-kDa Proteolytic Fragment (1-160) Andinhibited by the 16-kDa Fragment (1 - 95) of Recombinant Human Insulin-Like Growth Factor Binding Protein-3,” Growth Hormone & IGF Research, Vol. 8, No. 1, 1998, pp. 71-75.
 H. Shahjee, N. Bhattacharyya and G. Zappala, “An N-Terminal Fragment of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Induces Apoptosis in Human Prostate Cancer Cells in an IGF-Independent Manner,” Growth Hormone & IGF Research, Vol. 18, No. 3, 2008, pp. 188-197.
 Y. Oh, H. L. Muller, L. Ng and R. G. Rosenfeld, “Transforming Growth Factor-Beta-Induced Cell Growth Inhibition in Human Breast Cancer Cells Is Mediated through Insulin-Like Growth Factor-Binding Protein-3 Action,” Journal of Biological Chemistry, Vol. 270, No. 23, 1995, pp. 13589-13592. http://dx.doi.org/ 10.1074/jbc.270.23.13589
 Z. S. Gucev, Y. Oh, K. M. Kelley and R. G. Rosenfeld, “Insulin-Like Growth Factor Binding Protein 3 Mediates Retinoic Acidand Transforming Growth Factor Beta 2-Induced Growth Inhibition in Human Breast Cancer Cells,” Cancer Research, Vol. 56, 1996, pp. 1545-1550.
 G. R. Devi, D. L. Graham, Y. Oh and R. G. Rosenfeld, “Effect of IGFBP-3 on IGF and IGF-Analogue-Induced Insulin-Like Growth Factor-I Receptor (IGFIR) Signalling,” Growth Hormone & IGF Research, Vol. 11, No. 4, 2001, pp. 231-239. http://dx.doi.org/10.1054/ghir.2001.0231
 C. Lalou, C. Lassarre and M. Binoux, “A Proteolytic Fragment of Insulin-Like Growth Factor (IGF) Binding Protein-3 That Fails to Bind IGFs Inhibits the Mitogenic Effects of IGF-I and Insulin,” Endocrinology, Vol. 137, No. 8, 1996, pp. 3206-3212. http://dx.doi.org/10.1210/en.137.8.3206
 K. W. Colston, C. M. Perks, S. P. Xie and J. M. Holly, “Growth Inhibition of Both MCF-7 and Hs578T Human Breast Cancer Cell Lines by Vitamin D Analogues Is Associated with Increased Expression of Insulin-Like Growth Factor Binding Protein-3,” Journal of Molecular Endocrinology, Vol. 20, 1998, pp. 157-162.
 A. J. Butt, S. M. Firth, M. A. King and R. C. Baxter, “Insulin-Like Growth Factor-Binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-Independent Radiation-Induced Apoptosis in Human Breast Cancer Cells,” Journal of Biological Chemistry, Vol. 275, No. 50, 2000, pp. 39174-39181. http://dx.doi.org/10.1074/jbc.M908888199
 B. J. Boyle, X. Y. Zhao, P. Cohen and D. Feldman, “Insulin-Like Growth Factor Binding Protein-3 Mediates 1 Alpha, 25-Dihydroxyvitamin d(3) Growth Inhibition in the LNCaP Prostate Cancer Cell Line through p21/ WAF1,” Journal of Urology, Vol. 165, No. 4, 2001, pp. 1319-1324. http://dx.doi.org /10.1016/S0022-5347(01)69892-6
 D. R. Green, “Apoptotic Pathways: The Roads to Ruin,” Cell, Vol. 94, No. 6, 1998, pp. 695-698. http://dx.doi.org/10.1016/S0092-8674(00)81728-6
 S. Fanayan, S. M. Firth, A. J. Butt and R. C. Baxter, “Growth Inhibition by Insulin-Like Growth Factor-Binding Protein-3 in T47d Breast Cancer Cells Requires Transforming Growth Factor-Beta (TGF-Beta) and the Type II TGF-Beta Receptor,” Journal of Biological Chemistry, Vol. 275, No. 50, 2000, pp. 39146-39151. http://dx.doi.org/10.1074/jbc.M006964200
 S. Fanayan, S. M. Firth and R. C. Baxter, “Signaling through the Smad Pathway by Insulin-Like Growth Factor-Binding Protein-3 in Breast Cancer Cells. Relationship to Transforming Growth Factor-Beta 1 Signaling,” Journal of Biological Chemistry, Vol. 277, No. 9, 2002, pp. 7255-7261. http://dx.doi.org/ 10.1074/jbc.M108038200